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E V I D E N C E - B A S E D A N S W E R
Are major bleeding events from falls 
more likely in patients on warfarin?
■ Evidence summary
Increased risk of falling is often given as a
reason for not recommending anticoagula-
tion for atrial fibrillation in frail or elderly
patients. However, no studies directly
address the risk for major bleeding in anti-
coagulated patients who fall. 
One retrospective study of 2633 falls
in 1861 hospital inpatients compared the
rate of major hemorrhage between those
taking anticoagulation therapy with those
not taking it.1 Major hemorrhage was
defined as bruising or cuts requiring
immediate attention from a physician.
The rate of major hemorrhage was 6.2%
for patients taking warfarin and 11.3%
for patients receiving no therapy. Patients
with INR=2–3 had a major hemorrhage
rate of 6.9% compared with 10.1% for
those with INR <1.3. Criteria for using
warfarin were not reported; there may
have been selection bias in favor of pre-
scribing warfarin for patients judged less
likely to fall.
A smaller study of 400 consecutive
falls among 264 post-stroke patients in a
rehab hospital found no difference in
minor injury rates (19% vs 18%, NS); no
major hemorrhagic complications were
seen following 131 falls in the anticoagu-
lation group (93 patients) and 269 falls
in the group not on anticoagulation (175
There is no evidence of increased risk for major
bleeding as a result of falls in hospitalized patients
taking warfarin (strength of recommendation
[SOR]: B, based on retrospective cohort studies). 
In the average patient taking warfarin for atrial 
fibrillation, the risk of intracranial hemorrhage
from a fall is much smaller than the benefit gained
from reducing risk of stroke (SOR: A, based on
decision analysis of systematic reviews with 
sensitivity analysis).
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C L I N I C A L C O M M E N T A R Y
Major bleeding infrequent in fall patients with a
therapeutic INR; more common with higher INR
Decisions to initiate or withhold anticoagulation
can be difficult to make, but this Clinical Inquiry
should simplify matters. Clearly, for patients with
atrial fibrillation, the risk of stroke while not taking
warfarin is greater than the risk of major bleeding
from a fall while on it. Also, major bleeding from a
fall occurs infrequently in patients with a therapeu-
tic internal normalized ratio (INR). However, 
bleeding is more common in patients with a
supratherapeutic INR, so remain alert to possible
uncontrolled anticoagulation either from medica-
tion interactions or from impaired cognition.
This Clinical Inquiry should also help physicians
considering an inferior vena cava filter instead of
warfarin. Complications with inferior vena cava 
filters include death (0.82%), filter migration
(3%–69%), and penetration (9%–24%) or 
obstruction (6%–30%) of the inferior vena cava.6
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patients).2 Patients on anticoagulation
had an average protime of 16.1 seconds
(INR was not reported). The calculated
risk of major hemorrhage in an anticoag-
ulated patient from a single fall was
2.3% or less. The study was limited
because most falls were from a seated
position or partially controlled by an
attendant; few patients fell from a stand-
ing position.
Another study presented a Markov
decision analysis (comparison of risk esti-
mates in separate disease states) evaluat-
ing whether risk from falls should influ-
ence choice of anticoagulation therapy in
elderly patients with atrial fibrillation.3
Risk of intracranial bleeding from falls
was calculated from prospective cohort
studies and retrospective case series from
anticoagulation clinics, and stroke reduc-
tion benefit from anticoagulation was
taken from a meta-analysis of 5 random-
ized controlled trials. Sensitivity analyses
were performed to test the results of the
decision analysis. The calculated risk of
subdural hematoma from falling was
such that a patient with a 5% annual
stroke risk from atrial fibrillation would
need to fall 295 times in a year for the fall
risk to outweigh the stroke reduction ben-
efit of warfarin. 
Recommendations from others
Guidelines from the American Heart
Association and the American College of
Chest Physicians do not include fall risk in
the decision to use anticoagulation.4
Guidelines from the Institute for
Clinical Systems Improvement note that
patients with 3 falls in the previous year or
with recurrent, injurious falls were exclud-
ed from trials evaluating efficacy and 
safety of anticoagulation in patients with
nonvalvular atrial fibrillation.5
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